The apparatus comprehensive physiotherapy "biotar 1"

 

The invention relates to medical equipment and can be used for correction of functional disorders of man. The apparatus includes a cylindrical chamber of shielding electromagnetic radiation material with a polished inner surface. At the entrance to the chamber rotatably mounted laser emitter, the radiation of which is directed along the camera over your body. Person posted on the site, at the bottom of the camera. The laser emitter is equipped with a system of forming a blurred beam radiation. The beam covers all the cross-section of the chamber. The control system includes a computer connected ports to block reception of the optical signal and the control processor is connected to the Electromechanical unit, stepper motor which is connected with the laser emitter. At the bottom of the camera is equipped with a sound system for relaxation. The apparatus allows for the rapid regulation regimes impact due to the introduction of the feedback channel in the form of a recording unit of the optical signal. 9 C. p. F.-ly, 2 Il.

The invention relates to medical equipment and can be used in the local device therapeutic processing of biological tissues (EN 218/571, 1999) containing functionally interconnected irradiating the terminal installed in the nozzle sources of electromagnetic radiation in the infrared (IR) radiation and a photodetector, enclosed in a reflector made of metal, the inner surface of which is coated was highly reflective coating. The nozzle is connected to the control system, allowing to modulate the input to the radiation source power. The device allows optimal use of the properties of the treated tissue due to changes its state depending on the energy and spectrum of the impinging electromagnetic radiation.

However, the device can only be used in certain areas of the body, which limits its functionality, in addition to devices are missing the opportunity to work in the automated system in conjunction with an external computer.

A device for correction of biophysical field (EN 214/357, 1999), containing the camera in the form of a cylinder of aluminum alloy, installed horizontally. In the cavity of the cylinder has a helium-neon laser attached to the end face of the cylinder on a movable support so that the laser beam was directed along the longitudinal the stations with the ability to regulate its position on the vertical and horizontal axes and connected to the power supply. In the known device the electromagnetic radiation exposed to the entire body of the patient. However, the physiotherapy is carried out without taking into account the rapid diagnosis of the condition of the particular patient. Also it is not possible operational control modes and no indication of the progress of their execution.

The technical result of the invention is to eliminate the above disadvantages, increasing the effectiveness of treatment due to the formation of monochromatic light flux of the infrared range, when the current regulation modes bioresonance impact of radiation on the brain biorhythms and biological activity of the person on the functioning of individual organs and systems of life support.

The claimed technical result is achieved due to the fact that the device containing the camera has a cylindrical shape of the shielding electromagnetic radiation material with a polished inner surface, along the bottom of installed area for placement of the patient, and at the entrance of one of the ends of the chamber movably mounted unit of the laser oscillator with the possibility of sending its radiation along the longitudinal axis kameny COM ports 1 to the registration unit of the optical signal and the control processor, connected via LPT port to the Electromechanical unit, stepper motor which is installed with the possibility of rotating the laser emitter, equipped with a telescopic system of formation of blurred parallel beam made with the possibility of coverage beam the cross-section at the outlet side end of the camera, in addition, in the lower part at the ends of the camera system installed for relaxation of the patient.

Laser emitting apparatus can also be performed for modulation of the radiation.

In addition, the telescopic system of the emitter may include double-sided convex lens, and the laser emitter is a semiconductor.

Preferably, the power density of the laser beam was no more than 0.810-3W/cm2.

The recording unit of the optical radiation is commonly performed with the possibility of registration of radiation with a wavelength of from 0.5 to 25 μm and placed on top of the camera.

Speaker for relaxation is preferably quadratically.

In addition, the block of the laser emitter can be performed with the possibility of changing the speed of its rotation is placing the patient is mounted on a sliding frame, a cantilever at the entrance opposite end of the camera. The impact on the patient by using the proposed system, is the effect of electromagnetic radiation in the infrared range of the entire human body, which ensures the normalization biorhythm processes of the body, improve its functioning on an individual changes of parameters of radiation with automatic adjustment, which increases the effectiveness of physiotherapy treatment in a fairly wide spectrum of pathological conditions, ranging from emotional disorders to syndromes with an organic base, and allows to obtain positive changes in health during the first session, resulting in improved mood, increased activity (“the sensation of the flow of forces”), normalization of sleep, reduce the total voltage, the anxiety. Notes termination or significant weakening pain, itching.

A significant increase of the effect is achieved by the introduction into the apparatus of the feedback channel in the form of a recording unit of the optical radiation associated with the computer, with automatic correction of electromagnetic power, depending on the radiation Biol who synchronization effects, determined by the recording unit of the optical radiation in the infrared range, with minimal adaptation of the patient to electromagnetic stimuli and provides rapid recovery of homeostasis in the damaged tissues.

In Fig.1 presents a functional diagram of the apparatus of Fig.2 is a block diagram of the control system.

The complex physiotherapy apparatus includes a chamber of cylindrical shape 1 (Fig.1), the inner reflecting surface of which is polished and shields the radiation of the bio-object. Optimally performing camera solid aluminum alloy with a polished mirror inner surface and a wall thickness of not less than 10 mm. wall Thickness is selected from the exclusion of background radiation on the staff, and the wall thickness b>>where- wavelength radiation (estimated H.A. Kozyrev (Collection "Modeling and forecasting in Bioecology" Latvian state University n.a. P. Stucki, Riga, 1982)).

At the entrance of one of the ends of the camera is set to block the laser oscillator 7, which includes a telescopic system 12 (Fig.2) to form a parallel coherent beam of radiation, for example, the diameter of 110-170 mm in the volume of the chamber. Systemproperty 13, with a wavelength of 0.8 to 0.9 μm.

The power density of the laser beam is not more than 0.810-3W/cm2.

The power of the radiator 13 through the movable contacts from the interface module, including cost control laser power and DAC command signals from the control processor 9 of the control system 4 through the port. The distance between the laser emitter and the end face of the camera, as well as the optical parameters of the telescopic system are selected so that the generated parallel to the longitudinal axis camera monochromatic beam of radiation covered all the cross-section of the chamber. In the lower part of the chamber longitudinally installed Playground 6 for placing the patient in the supine position. The platform is mounted on a sliding frame (not shown), a cantilever at the entrance opposite end of the camera. The site is located in the cell without any contact with the inner surface of the cylinder.

The block rotation of the laser emitter is the stepper motor 10 through a mechanical system of gears, torque pad attached to it by a laser emitter 13. The laser light can be rotated with a predetermined speed, is ansto quantum stream.

Stepper motor 10 is included in the control unit and is connected through the control module 11 with LPT port control processor 9.

The recording unit of the optical signal 2 includes an IR photodiode, is connected through the amplifier and ADC to the computer operator. Block 2 is an element of the protection of the patient from exposure overdose and is used for rapid assessment of changes in the intensity of the reflected radiation in the optical range. IR photodiode registers albedo system reemission oral camera. The range of detected wavelengths from 0.5 to 25 μm at the boundary frequency of the optical signal of at least 10 MHz. The recording unit is installed in the upper part of the chamber.

Speaker for the relaxation of the patient 3 is installed at the bottom of the camera, the range of operating frequencies from 20 to 20,000 Hz. Most preferred is the use of quadratically system that allows you to deeply affect the patient.

Politicamente pathological process dictates the need for synchronization use therapeutic factors of electromagnetic radiation and, accordingly, automation of the process of tempering physiotherapeutic procedures with regard to diagnosing the presence of pathology, bio is a computer operator 8, control processor 9 is connected through the serial port.

Program selection the ongoing impact of its modes, monitoring their progress is a block of data entry computer operator 8.

The apparatus is used as follows.

Before the impact of selected optimal for this patient characteristics impact, taking into account information about the medical history obtained on the basis of preliminary studies, and selects the required program, it also compares the planned session with valid data recording unit of the optical signal.

The patient is placed on the platform 6, moved into the camera, he put on blacked out goggles, excluding the lateral flare of the eye. To register source AFR-radiation enters the recording unit of the optical signal. The obtained data are processed by a special computer program and results on the computer monitor of the operator.

Computer operator with the help of a special program through the LPT port on the control processor command is issued on the inclusion of opto-mechanical assemblies.

To facilitate the achievement of the patient's state of relaxation, one is locatel. Computer operator at the control processor as a sequence of commands serves the control signals of the mode options opto-mechanical assemblies and block the laser oscillator on the basis of data received from the recording unit of the optical signal received from the control processor to the control unit of the laser and the stepper motor in the form of analog signals, after which the electrical impulses are transferred directly to the laser emitter and the engine. At the end of a piece of music turns off all the equipment.

The patient is recommended to be not less than 1 min after switching off the device.

During treatment sessions, it is possible to perform smooth variation of the operating parameters on the request of the operator. All data is stored on your computer's hard drive with the possibility of migration on different data carriers.

Thus, in the internal volume of the chamber occurs luminous flux with a given pattern, twisting along the longitudinal axis of the camera, allowing you to get the exposure of the patient by the radiation of the light flux at multiple reflection from any toego air from 0to +40C at a relative humidity less than 90%.

Claims

1. Apparatus for physiotherapy containing chamber of the cylindrical form of shielding electromagnetic radiation material with a polished inner surface, along the lower part of which there is space for placement of the patient on the output of one of the ends of the chamber movably mounted unit laser radiation with a direction of its radiation along the longitudinal axis of the chamber above the body of the patient, wherein the system control device includes a computer operator, ports connected to the registration unit of the optical signal and the control processor is connected through ports to the Electromechanical unit, stepper motor which is installed with the possibility of rotating the laser emitter, equipped with a telescopic system of formation of blurred parallel beam made with the possibility of coverage beam the cross-section of the chamber at the inlet side of her face, and speaker for the relaxation of the patient is installed in the lower part, near the end of the camera.

2. The apparatus according to p. 1, otlichayushiesya fact, that telescopic system includes a two-sided convex lens.

4. The apparatus according to p. 1, wherein the laser emitter is made of a semiconductor.

5. Apparatus according to any one of paragraphs.1-4, characterized in that the power of the laser oscillator is made with the power density of the laser beam is not more than 0.8 to 10-3W/cm2.

6. Apparatus according to any one of paragraphs.1-5, characterized in that the recording unit of the optical radiation has a capability of recording radiation with a wavelength of from 0.5 to 25 μm and placed on top of the camera.

7. Apparatus according to any one of paragraphs.1-6, characterized in that the acoustic system for relaxation made quadratically.

8. Apparatus according to any one of paragraphs.1-7, characterized in that the power of the laser oscillator configured to change its speed of rotation.

9. Apparatus according to any one of paragraphs.1-8, characterized in that the body is made integral with a wall thickness of not less than 10 mm

10. Apparatus according to any one of paragraphs.1-9, characterized in that the space for placement of the patient mounted on a sliding frame, a cantilever at the entrance opposite end of the camera.

 

Same patents:

The invention relates to medicine, namely to Phthisiology

The invention relates to medicine, namely to pulmonology and physiotherapy
The invention relates to medicine, namely to reducing treatment in traumatology and orthopedics, and can be used in patients with arthrosis, osteochondrosis of the spine, herniated intervertebral disc, epicondylitis, bruises, syndrome title, carpal tunnel, etc

The invention relates to medicine, gynecology

The invention relates to medicine, gynecology, in particular, can be used in the treatment of background and precancerous diseases of the cervix during the rehabilitation period after local destruction
The invention relates to medicine, namely to gynecology
The invention relates to medicine, in particular to vascular surgery for the treatment of trophic ulcers of the lower limbs venous nature
The invention relates to medicine, namely to the way fluorescent diagnostics of malignant lesions of organs pleural or abdominal cavity
The invention relates to medicine, in particular to urology, and can be used for the treatment of hydrocele

FIELD: medicine.

SUBSTANCE: method involves introducing 0.1-0.3 ml of photosensitizing gel preliminarily activated with laser radiation, after having removed neovascular membrane. The photosensitizing gel is based on a viscoelastic of hyaluronic acid containing khlorin, selected from group containing photolon, radachlorine or photoditazine in the amount of 0.1-2% by mass. The photosensitizing gel is in vitro activated with laser radiation having wavelength of 661-666 nm during 3-10 min with total radiation dose being equal to 100-600 J/cm2. The gel is introduced immediately after being activated. To compress the retina, vitreous cavity is filled with perfluororganic compound or air to be further substituted with silicon oil. The operation is ended with placing sutures on sclerotomy and conjunctiva areas. Compounds like chealon, viscoate or hyatulon are used as viscoelastic based on hyaluronic acid. Perfluormetylcyclohexylperidin, perfluortributylamine or perfluorpolyester or like are used as the perfluororganic compound for filling vitreous cavity.

EFFECT: excluded recurrences of surgically removed neovascular membrane and development of proliferative retinopathy and retina detachment; retained vision function.

3 cl, 5 dwg

FIELD: medicine.

SUBSTANCE: method involves making incision in conjunctiva and Tenon's capsule of 3-4 mm in size in choroid hemangioma projection to sclera 3-4 mm far from limb. Tunnel is built between sclera and Tenon's capsule to extrasclerally introduce flexible polymer magnetolaser implant through the tunnel to the place, the choroid hemangioma is localized, after performing transscleral diaphanoscopic adjustment of choroid hemangioma localization and size, under visual control using guidance beam. The implant has permanent ring-shaped magnet in the center of which a short focus scattering lens of laser radiator is fixed. The lens is connected to light guide in soft flexible envelope. The permanent implant magnet is axially magnetized and produces permanent magnetic field of 2-3 mTesla units intensity. It is arranged with its north pole turned towards the choroid hemangioma so that extrascleral implant laser radiator disposition. The other end of the implant is sutured to sclera 5-6 mm far from the limb with two interrupted sutures through prefabricated openings. The implant is covered with conjunctiva and relaxation sutures are placed over it. Light guide outlet is attached to temple using any known method. 0.1-1% khlorin solution is injected in intravenous bolus dose of 0.8-1.1 mg/kg as photosensitizer and visual control of choroid hemangioma cells fluorescence and fluorescent diagnosis methods are applied. After saturating choroid hemangioma with the photosensitizer to maximum level, transscleral choroid hemangioma laser radiation treatment is carried out via laser light guide and implant lens using divergent laser radiation at wavelength of 661-666 nm with total radiation dose being equal to 30-120 J/cm2. The flexible polymer magnetolaser implant is removed and sutures are placed on conjunctiva. Permanent magnet of the flexible polymer magnetolaser implant is manufactured from samarium-cobalt, samarium-iron-nitrogen or neodymium-iron-boron system material. The photosensitizer is repeatedly intravenously introduced at the same dose in 2-3 days after the first laser radiation treatment. Visual intraocular neoplasm cells fluorescence control is carried out using fluorescent diagnosis techniques. Maximum level of saturation with the photosensitizer being achieved in the intraocular neoplasm, repeated laser irradiation of the choroid hemangioma is carried out with radiation dose of 30-60 J/cm2.

EFFECT: enhanced effectiveness of treatment.

4 cl

FIELD: medicine.

SUBSTANCE: method involves creating tunnel between sclera and Tenon's capsule in intraocular neoplasm projection. Intraocular neoplasm localization and size is adjusted by applying transscleral diaphanoscopic examination method. 0.1-0.3 ml of photosensitizing gel based on viscoelastic of hyaluronic acid, selected from group containing chealon, viscoate or hyatulon, is transsclerally introduced into intraocular neoplasm structure using special purpose needle in dosed manner. The photosensitizing gel contains khlorin, selected from group containing photolon, radachlorine or photoditazine in the amount of 0.1-1% by mass. Flexible polymer magnetolaser implant is extrasclerally introduced into the built tunnel in intraocular neoplasm projection zone under visual control using guidance beam. The implant has permanent ring-shaped magnet axially magnetized and producing permanent magnetic field of 3-4 mTesla units intensity, in the center of which a short focus scattering lens of laser radiator is fixed. The lens is connected to light guide in soft flexible envelope. The implant is arranged with its north pole turned towards the intraocular neoplasm so that implant laser radiator lens is extrasclerally arranged in intraocular neoplasm projection zone. The implant light guide is sutured to sclera 5-6 mm far from the limb with single interrupted suture. The implant is covered with conjunctiva and relaxation sutures are placed over it. Light guide outlet is attached to temple using any known method. Visual control of intraocular neoplasm cells is carried out by applying fluorescence and fluorescent diagnosis methods. After saturating the intraocular neoplasm with the photosensitizer to maximum saturation level, transscleral intraocular neoplasm laser radiation treatment is carried out via laser light guide and implant lens using divergent laser radiation at wavelength of 661-666 nm. The treatment course being over, the flexible polymer magnetolaser implant is removed and sutures are placed on conjunctiva. Permanent magnet of the flexible polymer magnetolaser implant is manufactured from samarium-cobalt, neodymium-iron-boron or samarium-iron-nitrogen. 0.1-1% khlorin solution as photosensitizer, selected from group containing photolon, radachlorine or photoditazine, is additionally intravenously introduced in 2-3 days at a dose of 0.8-1.1 mg/kg and repeated laser irradiation of the intraocular neoplasm is carried out with radiation dose of 30-45 J/cm2 15-20 min later during 30-90 s.

EFFECT: complete destruction of neoplasm; excluded its further growth.

4 cl

FIELD: medicine.

SUBSTANCE: method involves applying transscleral diaphanoscopic examination method for adjusting intraocular neoplasm localization and size. Rectangular scleral pocket is built 2/3 times as large as sclera thickness which base is turned from the limb. Several electrodes manufactured from a metal of platinum group are introduced into intraocular neoplasm structure via the built scleral pocket. Next to it, intraocular neoplasm electrochemical destruction is carried out in changing electrodes polarity with current intensity of 100 mA during 1-10 min, and the electrodes are removed. Superficial scleral flap is returned to its place and fixed with interrupted sutures. 0.1-2% aqueous solution of khlorin as photosensitizer, selected from group containing photolon, radachlorine or photoditazine, is intravenously introduced at a dose of 0.8-1.1 mg/kg. Visual control of intraocular neoplasm cells is carried out by applying fluorescence and fluorescent diagnosis methods. After saturating the intraocular neoplasm with the photosensitizer to maximum saturation level, transpupillary laser radiation of 661-666 nm large wavelength is applied at a dose of 30-120 J/cm2. the operation is ended with placing sutures on conjunctiva. Platinum, iridium or rhodium are used as the metals of platinum group. The number of electrodes is equal to 4-8. 0.1-1% khlorin solution, selected from group containing photolon, radachlorine or photoditazine, is additionally repeatedly intravenously introduced in 2-3 days at a dose of 0.8-1.1 mg/kg. Visual control of intraocular neoplasm cells is carried out by applying fluorescence and fluorescent diagnosis methods. After saturating the intraocular neoplasm with the photosensitizer to maximum saturation level, repeated laser irradiation of the intraocular neoplasm is carried out with radiation dose of 30-45 J/cm2.

EFFECT: complete destruction of neoplasm; excluded tumor recurrence; reduced risk of tumor cells dissemination.

3 cl, 3 dwg

FIELD: medicine.

SUBSTANCE: the present innovation deals with treating vascular cutaneous neoplasms, such as nevus flammeus and gemangiomas. Light-thermal impact at energy ranged 39-47 J/sq. cm should be performed in two stages, and between them, 2-3 wk after the onset of vascular resistance at the first stage one should perform beta-therapy daily for 2-3 d at single dosage being 20 g. Then, 3 wk later it is necessary to conduct the second stage of light-thermal impact by starting at energy value being 42 J/sq. cm, not less. The method enables to shorten therapy terms due to applying combined method to affect vascular cutaneous neoplasms.

EFFECT: higher therapeutic and cosmetic effect.

1 ex

FIELD: medicine.

SUBSTANCE: method involves intravitreously introducing two electrodes into intraocular neoplasm after carrying out vitrectomy and retinotomy to expose the intraocular neoplasm. The electrodes are manufactured from platinum group metal. Electrochemical destruction is carried out with current intensity of 100 mA during 1-10 min or 10 mA during 10 min in changing electrodes polarity and their position in the intraocular neoplasm space, and the electrodes are removed. 0.1-1% aqueous solution of khlorin as photosensitizer, selected from group containing photolon, radachlorine or photoditazine, is intravenously introduced at a dose of 0.8-1.1 mg/kg. Visual control of intraocular neoplasm cells fluorescence is carried out by applying fluorescent diagnosis methods. After saturating the intraocular neoplasm with the photosensitizer to maximum saturation level, intravitreous laser radiation is carried out in parallel light beam of wavelength equal to 661-666 nm is applied at a dose of 30-120 J/cm2.The transformed retina and tumor destruction products are intravitreally removed. Boundary-making endolasercoagulation of retinotomy area is carried out after having smoothed and compressed retina with perfluororganic compound. The operation is finished with placing sutures on sclerotomy and conjunctiva. Platinum, iridium or rhodium are used as the platinum group metals. Another embodiment of the invention involves adjusting position and size of the intraocular neoplasm in trans-scleral diaphanoscopic way. Rectangular scleral pocket is built above the intraocular neoplasm to 2/3 of sclera thickness with its base turned away from limb. Several electrodes are introduced into intraocular neoplasm structure via the built bed. The electrodes are manufactured from platinum group metal. Electrochemical destruction is carried out with the same current intensity in changing electrodes polarity and their position in the intraocular neoplasm space, and the electrodes are removed. Superficial scleral flat is returned to its place and fixed with interrupted sutures. 0.1-1% aqueous solution of khlorin as photosensitizer, selected from group containing photolon, radachlorine or photoditazine, is intravenously introduced at a dose of 0.8-1.1 mg/kg after having carried out vitrectomy and retinotomy. Visual control of intraocular neoplasm cells fluorescence is carried out by applying fluorescent diagnosis methods. After saturating the intraocular neoplasm with the photosensitizer to maximum saturation level, intravitreous laser radiation is carried out in parallel light beam of wavelength equal to 661-666 nm is applied at a dose of 30-120 J/cm2. The transformed retina and tumor destruction products are intravitreally removed using vitreotome. Boundary-making endolasercoagulation of retinotomy area is carried out after having smoothed and compressed retina with perfluororganic compound. The operation is finished with placing sutures on sclerotomy and conjunctiva. Platinum, iridium or rhodium are used as the platinum group metals. The number of electrodes is equal to 4-8.

EFFECT: reduced risk of metastasizing.

4 cl, 13 dwg

FIELD: medicine.

SUBSTANCE: method involves building tunnel to posterior eyeball pole in inferoexterior and superexterior quadrants. The tunnel is used for implanting flexible polymer magnetolaser implant to the place, the subretinal neovascular membrane is localized. The implant has a permanent magnet shaped as a cut ring and is provided with drug delivery system and a short focus scattering lens of laser radiator connected to light guide. The permanent implant magnet is axially magnetized and produces permanent magnetic field of 5-7 mTesla units intensity. It is arranged with its north pole turned towards sclera at the place of the subretinal neovascular membrane projection with extrascleral arrangement of laser radiator lens membrane being provided in the subretinal neovascular membrane projection area. The other implant end is sutured to sclera 5-6 mm far from the limb via holes made in advance. The implant is covered with conjunctiva and retention sutures are placed thereon. Light guide and drug supply system lead is attached to temple with any known method applied. Drugs are supplied via the implant drug supply system in retrobulbary way in any order. Triombrast is given in the amount of 0,4-0,6 ml and dexamethasone or dexone in the amount of 0,4-0,6 ml during 3-4 days every 12 h. 0.1-1% aqueous solution of khlorin is intravenously introduced at the third-fourth day after setting the implant as photosensitizer, selected from group containing photolon, radachlorine or photoditazine, at a bolus dose of 0.8-1.1 mg/kg. Visual control of subretinal neovascular membrane cells fluorescence is carried out by applying fluorescent diagnosis methods. After saturating the subretinal neovascular membrane with the photosensitizer to maximum saturation level, intravitreous, transretinal laser radiation of 661-666 nm large wavelength is applied at general dose of 30-120 J/cm2. The flexible polymer magnetolaser implant is removed and sutures are placed on conjunctiva. Permanent magnet of the flexible polymer magnetolaser implant is manufactured from samarium-cobalt, samarium-iron-nitrogen or neodymium-iron-boron system material. The photosensitizer is repeatedly intravenously introduced at the same dose in 2-3 days after the first laser radiation treatment. Visual intraocular neoplasm cells fluorescence control is carried out using fluorescent diagnosis techniques. Maximum level of saturation with the photosensitizer being achieved in the subretinal neovascular membrane via laser light guide and implant lens, repeated laser irradiation of the subretinal neovascular membrane is carried out with radiation dose of 30-60 J/cm2.

EFFECT: accelerated subretinal edema and hemorrhages resorption; regression and obliteration of the subretinal neovascular membrane; prolonged vision function stabilization.

6 cl

FIELD: medicine.

SUBSTANCE: method involves filling vitreous cavity with perfluororganic compound. Two electrodes manufactured from platinum group metal are intravitreally, transretinally introduced into intraocular neoplasm. Electrochemical destruction is carried out with current intensity of 10-100 mA during 1-10 min in changing electrodes polarity and their position in the intraocular neoplasm space, and the electrodes are removed. 0.1-1% aqueous solution of khlorin as photosensitizer, selected from group containing photolon, radachlorine or photoditazine, is intravenously introduced at a dose of 0.8-1.1 mg/kg. Visual control of intraocular neoplasm cells fluorescence is carried out by applying fluorescent diagnosis methods. After saturating the intraocular neoplasm with the photosensitizer to maximum saturation level, intravitreous, transretinal laser radiation of 661-666 nm large wavelength is applied at a dose of 30-120 J/cm2 in perfluororganic compound medium. The transformed retina and tumor destruction products are intravitreally removed with perfluororganic compound volume being compensated with its additional introduction. Boundary-making endolasercoagulation of retinotomy area is carried out. The perfluororganic compound is substituted with silicon oil. The operation is ended in placing sutures over sclerotmy areas and over conjunctiva. Perfluormetylcyclohexylperidin, perfluortributylamine or perfluorpolyester or like are used as the perfluororganic compound for filling vitreous cavity. Platinum, iridium or rhodium are used as the platinum group metals.

EFFECT: complete destruction of neoplasm; reduced dissemination risk.

6 cl, 12 dwg

FIELD: medicine, applicable for stopping of pains of various nature.

SUBSTANCE: the device has a quantum-mechanical oscillator located in a casing, magnet, vessel for medicinal agent and a hollow cylinder. The magnet is installed between the oscillator and the vessel. Positioned in the vessel is a hollow cylinder having through holes on its surface.

EFFECT: quick and absolute anestesia.

2 ex, 1 dwg

FIELD: medicine.

SUBSTANCE: method involves administering laser radiation therapy once a day using low intensity pulsating radiation of wavelength equal to 890nmand power density of 0.03 mW/cm2. Injured organ projection to frontal abdominal wall is exposed to radiation at the first laser therapy stage in two fields acting upon each field for 2 min with radiation pulse succession frequency equal to 80 Hz in applying stable contact-type method. Total treatment dose on two fields is equal to 0.008 J/cm2. The second laser therapy stage begins immediately after having finished the first one in applying radiation along the large intestine path using labile contact-type method in a way that radiation pulse succession frequency equal to 80 Hz is applied first during 1 min and then frequencies of 600, 150 and 300 Hz are applied also during 1 min, respectively. Total treatment dose is equal to 0.032 J/cm2 at the second stage. Total treatment dose is equal to 0.04 J/cm2 at both stages.

EFFECT: enhanced effectiveness in inhibiting dysbacteriosis; reduced frequency of postoperative complications.

Up!